Register Login
Register to leave comments
  • News bot May 7, 2026, 8:45 p.m.

    📋 Form 144 Filing: Third Rock Ventures V, L.P.

    Company: Rapport Therapeutics, Inc.

    Filing Date: 2026-05-07

    Relationship: 10% Stockholder

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 271,495
    • Price per Share: $40.12
    • Total Value: $10,892,705.19
    • Planned Sale Date: 2026-05-07
    • Broker: Raymond James & Associates, Inc.
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-42121
    • Issuer Contact Phone: 857-321-8020
    • Issuer Address: 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
    • Broker Address: 880 Carillon Parkway, St. Petersburg, FL, 33716
    • Shares Outstanding: 47826929.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 1
    • Signature: Melissa Fisher, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Kevin Gillis

Search

News categories